Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin J Am Soc Nephrol. 2014 Apr;9(4):812-4. doi: 10.2215/CJN.12601213. Epub 2014 Jan 23.

Dialysis therapies: a National Dialogue.

Author information

1
Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington;, †Ohio State University, Columbus, Ohio;, ‡University Health Network, Toronto, Ontario, Canada;, §University of California, San Francisco, California;, ‖Oregon Health and Science University, Portland, Oregon;, ¶Emory University, Atlanta, Georgia, *National Institute of Diabetes, Digestive, and Kidney Disease, National Institutes of Health, Bethesda, Maryland.

Abstract

The National Institute of Diabetes, Digestive, and Kidney Diseases-supported Kidney Research National Dialogue asked the scientific community to formulate and prioritize research objectives that would improve our understanding of kidney function and disease. Kidney Research National Dialogue participants identified the need to improve outcomes in ESRD by decreasing mortality and morbidity and enhancing quality of life as high priority areas in kidney research. To reach these goals, we must identify retained toxins in kidney disease, accelerate technologic advances in dialysate composition and devices to remove these toxins, advance vascular access, and identify measures that decrease the burden of disease in maintenance dialysis patients. Together, these research objectives provide a path forward for improving patient-centered outcomes in ESRD.

PMID:
24458085
PMCID:
PMC3974371
DOI:
10.2215/CJN.12601213
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center